Long intergenic non-protein coding RNA 2264 (LINC02264)

Long intergenic non-protein coding RNA 2264 (LINC02264) is a human long intergenic non-coding RNA (lincRNA), classified as a long non-coding RNA over 200 nucleotides in length that does not overlap protein-coding genes[1][3]. LincRNAs like LINC02264 commonly function by regulating transcription, modulating chromatin architecture, and fine-tuning expression of other genes, often with tissue specificity[3]. There is no current evidence that LINC02264 acts as a therapeutic target, is druggable, or has a defined disease-association; its functions and clinical significance remain largely uncharacterized[1][3]. Supporting Details: - According to GeneCards, LINC02264 is annotated as a long intergenic non-protein coding RNA gene, but no associated protein products, pathways, or disorder associations are listed for this gene[1]. - Long intergenic non-coding RNAs overall are known to regulate gene expression and chromatin states, but only a small fraction have been experimentally characterized for specific biological functions or disease associations[3]. - No literature identifies LINC02264 as a therapeutic target, nor are there established drugs, mechanisms of action, biomarkers, or notable safety concerns associated with LINC02264[1][3].

Other names

LINC02264